Acute Renal Failure: An Endotoxin Hyper-Responsive State

急性肾衰竭:内毒素高反应状态

基本信息

  • 批准号:
    8118789
  • 负责人:
  • 金额:
    $ 35.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-01 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In the aftermath of acute renal injury (AKI), proximal tubular cells manifest dramatic hyper-responsiveness to Toll receptor ligands, most notably, endotoxin. This exaggerates renal cytokine (e.g., TNF-1) / chemokine (e.g., MCP-1) production which can worsen the severity of acute renal failure (ARF). With renal venous cytokine efflux, extra-renal injury may also result. This LPS hyper-responsiveness is transcriptionally regulated, and mediated, in part, by gene activating chromatin events. The overall goal of this proposal is to: i) further define the pathways which induce the underlying chromatin changes; and ii) delineate how they mediate an exaggerated LPS responsive state. To focus the application, one ARF model (ischemia/reperfusion) 1 exposure to one Toll ligand (LPS) will be tested in three Specific Aims: Aim#1: Define the temporal sequence of chromatin changes along the TNF-1 gene in AKI. We will characterize chromatin changes, including CpG methylation/demethylation, histone acetylation, methylation, histone variants, and alterations in nucleosome positions. Both renal injury, and proximal tubule-specific injury (in cultured tubular HK-2 cells), will be studied following reversible ischemia + LPS. These in vivo and in vitro experiments will set the stage for mechanistic assessments (Aim 3). Aim #2: Ascertain which transcription and chromatin remodeling factors / enzymes are recruited to the TNF-1 gene in AKI. We have already shown that the chromatin remodeler BRG1 is recruited to the TNF-1 gene and is required for injury-induced TNF-1 transcription. We have also demonstrated that NF-:B and AP-1 transcription factors are recruited to the TNF-1 gene in AKI. Using Matrix ChIP, we will more fully define the spatiotemporal sequence of chromatin and transcription events at the TNF-1 gene in response to reversible ischemia + LPS. This will help to ascertain which factors are hyper-recruited to the TNF-1 gene and may thus drive the LPS hyper-responsive state. Aim #3 Test the mechanistic relevance of the above defined changes in the induction of the LPS hyper-responsive state. The mechanistic relevance of the above defined changes in establishing LPS hyper-responsiveness will be tested both in vitro and in vivo using siRNA targeting (as we have already done to knock-down BRG1 in HK-2 cells). We will complement these in vivo and in vitro siRNA approaches with the use of pharmacologic reagents directed at the putative molecular mediators of the hyper-responsive chromatin state. The latter approach may lead to therapeutically relevant translational approaches for modulating experimental AKI and associated multiorgan failure. The proposed studies are highly novel in that, with the exception of data obtained by the PIs, virtually no information exists as to the nature, and consequences of, chromatin alterations in response to AKI. Hence, new perspectives on mechanisms of AKI and its downstream consequences should result. PUBLIC HEALTH RELEVANCE: Acute kidney injury (AKI) leads to renal production of inflammatory mediators and sensitizes/primes the kidney to bacterial toxins. These renal inflammatory mediators gain access to the systemic circulation and can induce extra-renal tissue damage, a common cause of mortality in patients with AKI, due to infections, trauma and other illness. We propose to define the chromatin/transcriptional mechanisms for these renal responses with the goal to develop preventive treatments in the future.
描述(由申请人提供):在急性肾脏损伤(AKI)之后,近端管状细胞表现出对收费受体配体的显着性超反应性,最著名的是内毒素。这夸大了肾细胞因子(例如TNF-1) /趋化因子(例如MCP-1)的产生,这可能会使急性肾衰竭(ARF)的严重程度恶化。随着肾静脉细胞因子外排,可能会导致肾上腺外损伤。该LPS超反应性受到转录调节,并部分通过激活染色质事件的基因介导。该提案的总体目标是:i)进一步定义诱导潜在染色质变化的途径; ii)描述它们如何介导夸张的LPS响应状态。为了集中应用,将在三个特定的目标中测试一个ARF模型(缺血/再灌注)1接触一个收费配体(LPS):AIM#1:定义AKI中TNF-1基因的染色质变化的时间序列。我们将表征染色质的变化,包括CpG甲基化/脱甲基化,组蛋白乙酰化,甲基化,组蛋白变异以及核小体位置的改变。在可逆性缺血 + LPS之后,将研究肾脏损伤和近端小管特异性损伤(在培养的管状HK-2细胞中)。这些体内和体外实验将为机械评估奠定阶段(AIM 3)。 目标#2:确定哪些转录和染色质重塑因子 /酶被募集到AKI中的TNF-1基因。我们已经表明,将染色质重塑剂BRG1募集到TNF-1基因,是损伤诱导的TNF-1转录所必需的。我们还证明了NF-:B和AP-1转录因子被募集到AKI中的TNF-1基因。使用矩阵芯片,我们将更全面地定义TNF-1基因在TNF-1基因上的时空序列,以响应可逆性缺血 + LP。这将有助于确定哪些因素已超过TNF-1基因,因此可能会驱动LPS超反应态。 AIM#3测试了上述LPS超响应状态诱导上上述定义变化的机理相关性。上述确定LPS超反应性变化的机理相关性将在体外和体内使用siRNA靶向进行测试(就像我们已经在HK-2细胞中敲低BRG1的那样)。我们将使用针对高反应性染色质状态的推定分子介质的药理试剂来补充这些体内和体外siRNA方法。后一种方法可能会导致用于调节实验AKI和相关多机器人失败的治疗相关的翻译方法。 提出的研究是高度新颖的,因为除了PIS获得的数据外,几乎不存在有关染色质改变对AKI的性质和后果的信息。因此,应该导致对AKI机制及其下游后果的新观点。 公共卫生相关性: 急性肾脏损伤(AKI)导致炎症介质的肾脏产生,并使肾脏对细菌毒素进行敏感/素。这些肾脏炎症介质可以进入全身循环,并可能诱导肾外组织损伤,这是由于感染,创伤和其他疾病而导致AKI患者死亡的常见原因。我们建议定义这些肾脏反应的染色质/转录机制,以未来开发预防性治疗的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAROL BOMSZTYK其他文献

KAROL BOMSZTYK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAROL BOMSZTYK', 18)}}的其他基金

Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker Assay
预分析因素对球母细胞瘤 MGMT 启动子甲基化生物标志物测定的影响
  • 批准号:
    9975358
  • 财政年份:
    2020
  • 资助金额:
    $ 35.13万
  • 项目类别:
Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker Assay
预分析因素对球母细胞瘤 MGMT 启动子甲基化生物标志物测定的影响
  • 批准号:
    10415839
  • 财政年份:
    2020
  • 资助金额:
    $ 35.13万
  • 项目类别:
Transcriptional and epigenetic control of angiogenic genes in sepsis-induced acute kidney injury.
脓毒症引起的急性肾损伤中血管生成基因的转录和表观遗传控制。
  • 批准号:
    9173657
  • 财政年份:
    2016
  • 资助金额:
    $ 35.13万
  • 项目类别:
Transcriptional and epigenetic control of angiogenic genes in sepsis-induced acute kidney injury.
脓毒症引起的急性肾损伤中血管生成基因的转录和表观遗传控制。
  • 批准号:
    9334850
  • 财政年份:
    2016
  • 资助金额:
    $ 35.13万
  • 项目类别:
Integrated microplate platform for epigenetic analysis
用于表观遗传分析的集成微孔板平台
  • 批准号:
    8754755
  • 财政年份:
    2014
  • 资助金额:
    $ 35.13万
  • 项目类别:
Integrated microplate platform for epigenetic analysis
用于表观遗传分析的集成微孔板平台
  • 批准号:
    9066225
  • 财政年份:
    2014
  • 资助金额:
    $ 35.13万
  • 项目类别:
Acute Renal Failure: An Endotoxin Hyper-Responsive State
急性肾衰竭:内毒素高反应状态
  • 批准号:
    8305648
  • 财政年份:
    2010
  • 资助金额:
    $ 35.13万
  • 项目类别:
Acute Renal Failure: An Endotoxin Hyper-Responsive State
急性肾衰竭:内毒素高反应状态
  • 批准号:
    8541828
  • 财政年份:
    2010
  • 资助金额:
    $ 35.13万
  • 项目类别:
Acute Renal Failure: An Endotoxin Hyper-Responsive State
急性肾衰竭:内毒素高反应状态
  • 批准号:
    7982459
  • 财政年份:
    2010
  • 资助金额:
    $ 35.13万
  • 项目类别:
LAMININ GENE EXPRESSION IN GLOMERULAR CELLS
肾小球细胞中的层粘连蛋白基因表达
  • 批准号:
    7921107
  • 财政年份:
    2009
  • 资助金额:
    $ 35.13万
  • 项目类别:

相似国自然基金

抑制MBD2通过下调Rac1和Pcbp2保护脓毒症AKI的机制研究
  • 批准号:
    81870475
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
Gasdermin家族蛋白介导的细胞程序性坏死在急性肾衰竭中的作用
  • 批准号:
    81700596
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
基于腺苷相关蛋白同步化表达探讨缺血预适应保护急性肾功能衰竭的分子机制
  • 批准号:
    81200540
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
生物人工肾小管治疗ARF/MODS的免疫调节作用
  • 批准号:
    30570862
  • 批准年份:
    2005
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

Ceramides as Novel Mediators of Tubular Metabolic Dysfunction Driving Kidney Injury
神经酰胺作为肾小管代谢功能障碍驱动肾损伤的新型调节剂
  • 批准号:
    10677394
  • 财政年份:
    2023
  • 资助金额:
    $ 35.13万
  • 项目类别:
A Randomized Clinical Trial of Continuous vs. Intermittent Infusion Vancomycin: Effects on Measured GFR and Kidney Injury Biomarkers
连续与间歇输注万古霉素的随机临床试验:对测量的 GFR 和肾损伤生物标志物的影响
  • 批准号:
    10647236
  • 财政年份:
    2023
  • 资助金额:
    $ 35.13万
  • 项目类别:
Save Kidneys in Cisplatin Chemotherapy by blocking HDAC6
顺铂化疗中通过阻断 HDAC6 拯救肾脏
  • 批准号:
    10841270
  • 财政年份:
    2023
  • 资助金额:
    $ 35.13万
  • 项目类别:
Effect of High Salt Diet on Proximal Tubular Sodium Reabsorption, Metabolic Stress, and Injury
高盐饮食对近端肾小管钠重吸收、代谢应激和损伤的影响
  • 批准号:
    10908784
  • 财政年份:
    2023
  • 资助金额:
    $ 35.13万
  • 项目类别:
Personalized Risk Prediction for Prevention and Early Detection of Postoperative Failure to Rescue
个性化风险预测,预防和早期发现术后抢救失败
  • 批准号:
    10753822
  • 财政年份:
    2023
  • 资助金额:
    $ 35.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了